Phase 1 Peritoneal Metastases Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
Colorectal, CancerPeritoneal MetastasesCarcinomatosis
M.D. Anderson Cancer Center28 enrolled1 locationNCT07411599
Recruiting
Phase 1
CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases
Peritoneal Metastases From Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University12 enrolled1 locationNCT07247396
Recruiting
Phase 1
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
Colorectal, CancerPancreatic CancerGastric Cancer+5 more
University Hospital, Ghent45 enrolled1 locationNCT05277766
Recruiting
Phase 1
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Liver CancerEsophageal CancerGastric Cancer+9 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)18 enrolled1 locationNCT07001592
Recruiting
Phase 1
PIPAC for Peritoneal Metastases
Peritoneal Metastases
National Cancer Centre, Singapore25 enrolled1 locationNCT04956068